Suicidal Behavior Among Schizophrenic Patients

NCT07145840 | Completed

• 1 other identifier: 35394/4/22
• Study Type: observational
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

This study aimed to; -

1. 1.Study suicidal behavior among sample of schizophrenic patients.
2. 2.Study relation between schizophrenic symptoms and suicidal behavior.
3. 3.Study the relation of mood symptoms in schizophrenic patients and suicidal behavior.

Conditions

Suicidal Behavior; Schizophrenic Patients

Outcome Measures

Primary Outcomes (1)

• Severity of Suicidal Ideation

  Assessed using the Arabic version of the Beck Scale for Suicide Ideation (BSS), which includes 21 statement groups rated on a 3-point scale. The total score ranges from 0 to 38, with higher scores indicating more severe suicidal ideation.

  Within 1 week prior to assessment

Secondary Outcomes (2)

• Severity of Schizophrenia Symptoms

  Within 7 days

• Severity of Depressive Symptoms

  Within 7 days

Study Arms (2)

Group A

Patients with schizophrenia. They had a current history of suicide ideation or attempt.

Other: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)

Group B

Patients with schizophrenia without any history of neither suicide ideation nor attempt.

Other: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)

Interventions

Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) OTHER

Psychiatric interview for diagnosis of schizophrenia by SCID 5 (American Psychiatric Association, 2015), The Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) is a semi structured interview guide for making the major DSM-5 diagnoses using the chapter of schizophrenia spectrum

Group A; Group B

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

This cross-sectional study was carried out on patients diagnosed with schizophrenia recruited from inpatient and outpatient services of the Department of Neuropsychiatry and Center of Psychiatry, Neurology, Tanta University Hospitals, Egypt.

You may qualify if:

• Age between 18 and 60.
• Both females and males will be included.
• All patients should meet the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for schizophrenia.

You may not qualify if:

• Any neurological disorder.
• Past history of head trauma.
• Medical or autoimmune disorders.
• Other psychiatric disorders e. g. bipolar disorders, post-traumatic stress disorder (PTSD), obsessive compulsive disorder (OCD), and anxiety.
• Pregnancy.

Sponsors & Collaborators

• Tanta University: lead

Study Sites (1)

Tanta University

Tanta, El-Gharbia, 31527, Egypt

Location

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Resident of Neuropsychiatry Department, Faculty of Medicine, Tanta University, Tanta, Egypt.

Study Record Dates

• First Submitted: August 21, 2025
• First Posted: August 28, 2025
• Study Start: April 30, 2022
• Primary Completion: March 30, 2023
• Study Completion: March 30, 2023
• Last Updated: August 28, 2025

Record last verified: 2025-08

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: After the end of study for one year.
• Access Criteria: The data will be available upon a reasonable request from the corresponding author.

Locations

EG (1)